BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8653621)

  • 1. [New treatments for multiple sclerosis].
    Masdeu JC
    Rev Neurol; 1996 Jun; 24(130):708-11. PubMed ID: 8653621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined treatment of multiple sclerosis. A case report].
    Fonseca A; Noda M; González I; Gámez O; Montoya A; Daudinot B
    Rev Neurol; 2001 May 16-31; 32(10):996-8. PubMed ID: 12809119
    [No Abstract]   [Full Text] [Related]  

  • 3. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences with immunosuppressive treatment of multiple sclerosis].
    Wieczorek V; Lehnert W; Brodkorb W
    Dtsch Gesundheitsw; 1971 Sep; 26(38):1791-4. PubMed ID: 5142348
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.
    Patti F; Amato MP; Filippi M; Gallo P; Trojano M; Comi GC
    J Neurol Sci; 2004 Aug; 223(1):69-71. PubMed ID: 15261564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():23-6. PubMed ID: 829627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disease-modifying treatments in multiple sclerosis].
    Confavreux C; Bouhour F; Vukusic S
    Rev Prat; 1999 Nov; 49(17):1882-9. PubMed ID: 10598505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 9. New treatments for multiple sclerosis.
    Hutchinson M
    Ir Med J; 1996; 89(2):44. PubMed ID: 8682623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pragmatic approach to treatments in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F125-31. PubMed ID: 19593885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined therapy in multiple sclerosis].
    García-Merino JA; Blasco-Quítez MR; Ortiz-Benítez P; Puerta C
    Rev Neurol; 2003 Mar 16-31; 36(6):545-9. PubMed ID: 12652419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children and adolescents with multiple sclerosis.
    Banwell B
    Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive therapy of multiple sclerosis using cyclophosphamide with few side effects].
    Kornhuber HH; Mauch E
    Dtsch Med Wochenschr; 1986 Nov; 111(46):1778. PubMed ID: 3780443
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multiple sclerosis].
    Offenhäusser M; Martin R
    Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].
    Skłodowski P
    Neurol Neurochir Pol; 1993; 27(6):877-83. PubMed ID: 8164783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
    Szczepanik M; Tutaj M; Filipczak-Bryniarska I; Bryniarski K
    Przegl Lek; 2005; 62(2):115-8. PubMed ID: 16095157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving the MS puzzle.
    Hobson K
    US News World Rep; 2002 Oct; 133(13):60-2. PubMed ID: 12375480
    [No Abstract]   [Full Text] [Related]  

  • 18. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
    Lebrun C; Debouverie M; Vermersch P; Clavelou P; Rumbach L; de Seze J; Wiertlevski S; Defer G; Gout O; Berthier F; Danzon A
    Mult Scler; 2008 Apr; 14(3):399-405. PubMed ID: 18420778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C; Vukusic S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.